This study opens the door to a new strategy to sensitize this subtype of breast cancer to immunotherapy.The goal is to work towards turning this modified LCOR into a therapy that can be investigated i...
Read moreThe international DESTINY-Breast05 trial, published in The New England Journal of Medicine, demonstrates that the antibody-drug conjugate trastuzumab deruxtecan (T-DXd) reduces by half the risk of inv...
Read moreThe IDIBELL-ICO study, in collaboration with the IJC, shows that the blockade of the pseudogene RPSAP52 in ovarian cancer reduces tumor growth without showing obvious signs of toxicity in preclinical ...
Read moreThe study, conducted using data from the Granada Cancer Registry, shows that for women diagnosed with breast cancer, the risk of developing another primary cancer is 33% higher than in the general pop...
Read moreLa microbiota intestinal, formada por los microorganismos que habitan en el intestino, desempeña un papel clave en la digestión, el metabolismo y la regulación del sistema inmunitario. Durante el e...
Read moreDemuestran que la administración de hierro intravenoso, añadida a la profilaxis oral habitual, aumenta la concentración de hemoglobina materna antes del parto en mujeres embarazadas con deficiencia...
Read moreOriva Therapeutics, a women’s health company developing first-in-class and best-in-class approaches to treat chronic, prevalent conditions affecting women, announced today its incorporation, as well...
Read moreLas células utilizadas en la terapia corresponden a una subpoblación CD133+ derivada de médula ósea, previamente caracterizada por su capacidad regenerativa en el tejido endometrial, lo que refuer...
Read moreAs every year, World Cancer Day is commemorated on February 4. One of the greatest challenges of modern medicine is finding reliable diagnoses and effective treatments for the different types of cance...
Read morePATINA es un ensayo fase III, aleatorizado y multicéntrico, liderado por Alliance Foundation Trials (AFT), que evalúa la eficacia y seguridad de añadir palbociclib al tratamiento de mantenimiento e...
Read moreA study led from Lleida has developed an experimental model based on CRISPR/Cas9 to simultaneously edit several tumour suppressor genes and generate cells that reproduce molecular and morphological ch...
Read moreDentro del total de la financiación anunciada, la Ayuda Estudios Clínicos AECC, dotada de un millón de euros, apoya un pionero ensayo clínico con virus modificados para el tratamiento de tumores c...
Read more